Infigratinib in Recurrent High-Grade Glioma Patients

NCT04424966 · clinicaltrials.gov ↗
EARLY_PHASE1
Phase
TERMINATED
Status
7
Enrollment
OTHER
Sponsor class

Stopped Study drug no longer available.

Conditions

Interventions

Sponsor

Nader Sanai

Collaborators